WINDLAS BIOTECH LTD.

NSE : WINDLASBSE : 543329ISIN CODE : INE0H5O01029Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 19926.34 Face Value (Rs.) : 5 House : Private
BSECurrent Price (Rs.) 965.60Change (Rs.)48.25 (+5.26 %)
PREV CLOSE (Rs.) 917.35
OPEN PRICE (Rs.) 912.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 17026
TODAY'S LOW / HIGH (Rs.)912.55 999.00
52 WK LOW / HIGH (Rs.)699.35 1095
NSECurrent Price (Rs.) 964.95Change (Rs.)47 (+5.12 %)
PREV CLOSE( Rs. ) 917.95
OPEN PRICE (Rs.) 919.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 964.95 (747)
VOLUME 434776
TODAY'S LOW / HIGH(Rs.) 915.05 1000.60
52 WK LOW / HIGH (Rs.)697.4 1097.9

SMART QUOTES

STOCK SUMMARY

Trade Value (Rs. in Lacs)
164.92
Dividend Yield(%)
0.65
TTM EPS (Rs.)
32.19
P/E Ratio
30.00
Book Value (Rs.)
257.71
Face Value (Rs.)
5
MCap (Rs. in Mn)
19926.34
Price/Earning (TTM)
20.56
Price/Sales (TTM)
2.12
Price/Book (MRQ)
3.75
PAT Margin (%)
ROCE (%)

COMPANY INFO

Incorporation Year : 19-02 2001

Management Info :

Vivek Dhariwal - Chairman Hitesh Windlass - Managing Director

Registered Office :

Address : 40 / 1,Mohabewala Industrial Area,,
Dehradun,
Uttarakhand-248110

Phone : 0135-6608000-30

Registrars Details :

MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

01Jul Windlas Biotech submits AGM notice
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
18May Submission Of Post Buyback Public Ann
Post Buyback Public Advertisement pursuant to and in compliance with Buy..
15Apr Windlas Biotech informs about board me
Windlas Biotech has informed that a meeting of the Board of Directors of..

FINANCIALS

QTR Jun 26 ANNUAL 26
Net Profit176.53664.35
Gross Profit 229.36 869.31
Operating Profit 317.92 1224.99
Net Sales 2480.99 9040.89
Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

PEER GROUP

Glaxosmithkline Phar (BSE)
 3034.05 (5.23%)
M.Cap (Rs. in Cr)51398.64
Pfizer (BSE)
 4917.35 (2.43%)
M.Cap (Rs. in Cr)22495.76
Sudeep Pharma (BSE)
 1156.00 (4.98%)
M.Cap (Rs. in Cr)13056.86
Caplin Point Labs. (BSE)
 2571.00 (1.61%)
M.Cap (Rs. in Cr)19542.61

SHAREHOLDING PATTERN

PROMOTERS
63.31%
NON-INSTITUTION
24.8%
MUTUAL FUNDS/UTI
5.76%
FI/BANKS/INSURANCE
0%
GOVERNMENT
0%
FII
0%